Shared Resource 03: Biostatistics (BSR)
共享资源 03:生物统计学 (BSR)
基本信息
- 批准号:10333291
- 负责人:
- 金额:$ 32.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-12 至 2025-11-30
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAdverse eventAreaArtificial IntelligenceBasic ScienceBioconductorBiologicalBiometryBiostatistics Shared ResourceBudgetsCancer BiologyCancer Center Support GrantCancer ControlCancer HospitalCancer SurvivorshipCenter for Translational Science ActivitiesChemopreventionClinicalClinical Cancer CenterClinical DataClinical SciencesClinical TreatmentClinical TrialsCollaborationsCommunitiesComparative PathologyComprehensive Cancer CenterDataData AnalysesDatabasesDevelopmentDiseaseEducationEducational workshopElectronic Health RecordEngineeringEnsureFAIR principlesFacultyFlow CytometryFundingFutureGenomicsGrantGuidelinesHealth Insurance Portability and Accountability ActHealth Services ResearchHourImmunologic MonitoringImmunooncologyIndividualInformaticsInfrastructureInstitutesInstitutional Review BoardsInterventionIntramural Research ProgramLogisticsMachine LearningMalignant Childhood NeoplasmMalignant NeoplasmsManuscriptsMethodologyMethodsMicroscopyMissionModelingMolecular CarcinogenesisMonitorMulti-Institutional Clinical TrialNCI Center for Cancer ResearchNutrientOhioOncologyOutcomes ResearchPediatric HospitalsPersonsPharmaceutical ChemistryPhytochemicalPopulation ResearchPopulation StudyPreparationProceduresProcessProteomicsProtocols documentationPublicationsPublishingRegistriesReportingReproducibilityResearchResearch ActivityResearch DesignResearch InstituteResearch MethodologyResearch PersonnelResource SharingResourcesReview CommitteeRoleSafetyScienceScientistServicesStatistical Data InterpretationSurveysSystemTechnologyTrainingTraining and EducationTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkanimal imaginganticancer researchbasebiomedical informaticscancer carecancer preventiondata qualitydata visualizationdesigndigital imagingepidemiology studyexperimental studygenomic datahealth disparityinnovationleukemialeukemia tissue bankmaterial transfer agreementmembermultidimensional datanext generation sequencingpathology imagingpatient orientedpopulation basedprofessorprogramsquery toolsranpirnaserecruitresearch studysingle-cell RNA sequencingsoundtooltranslational genomicstranslational therapeuticsworking group
项目摘要
PROJECT SUMMARY – BIOSTATISTICS SHARED RESOURCE (BSR)
The BSR provides a centralized resource of expertise in the biostatistical and design aspects of
clinical/translational, basic, and population-based cancer research. The specific aims of the BSR are to: 1)
collaborate with OSUCCC investigators in all aspects of quantitative translational research including study
design, training and education, reproducibility and scientific rigor, statistical analysis, data visualization, and
manuscript and report preparation; 2) enable strong and consistent collaborations by providing a biostatistical
“navigator” to all OSUCCC research programs and Disease Specific Research Groups (DSRGs), and by
providing education and biostatistical training to OSUCCC members; and 3) provide biostatistical and
methodological review of all cancer protocols submitted to the OSUCCC Clinical Scientific Review Committee
(CSRC) and Data Safety Monitoring Committee (DSMC), and as needed for the Total Cancer Care (TCC)
research committee for the BSSR. To bolster team science in cancer research, BSR established a navigator-
system in 2013, now expanded over the current cycle to 20 different groups at OSU and Nationwide Children's
Hospital (NCH), whereby biostatisticians are embedded within each DSRG and are involved with all research
studies from their inception. Navigators are intimately familiar with the clinical, biological, and statistical issues
they support and serve as point persons for establishing collaborations between these groups and the broader
OSU community. Office hours were established within all five OSUCCC programs, where the navigator
biostatistician spends half a day every other week at a provided space. BSR also actively developed workshops,
seminars, and courses devoted to training biomedical investigators in the fundamentals of design, analysis, and
scientific rigor. Over the current cycle, BSR supported individual investigators using genomic data from the TCC
protocol, the Oncology Research Information Exchange Network (ORIEN) Avatar program at OSU, and the
National Patient-Centered Research Clinical Network (PaTH) by providing computational and programming
support, data visualization, graphical and query tools, and data interpretation. BSR works together with other
shared resources and the DSMC and CSRC in the development and implementation of protocols to ensure
HIPAA compliant processes, and high data quality by enforcing the application of Findable, Accessible,
Interoperable, and Reusable (FAIR) guidelines. During the current cycle, the BSR supported 405 publications
(59 > 10 impact factor) and 98 NIH (53 NCI) grants including 26 R01s, 35 R21s, 1 R03, 14 U01s, 5 U24s, 3
U19s, 3 U54s, 8 P01s, 2 P30s, 1 P50. Over the next grant cycle, the BSR's role in the new strategic priorities for
the OSUCCC, including immuno-oncology, translational genomics, cancer engineering and cancer prevention
and survivorship will substantially increase the BSR's contributions, and will specifically include new recruits and
technologies. The annual budget of the BSR is $4,063,515, yet the CCSG request is $231,260. As such, the
BSR leverages extensive institutional support and seeks only 5.7% support from CCSG funds.
项目摘要 – 生物统计共享资源 (BSR)
BSR 提供生物统计和设计方面的集中专业知识资源
临床/转化、基础和基于人群的癌症研究。 BSR 的具体目标是: 1)
与 OSUCCC 研究人员在定量转化研究的各个方面进行合作,包括研究
设计、培训和教育、可重复性和科学严谨性、统计分析、数据可视化和
手稿和报告的准备; 2)通过提供生物统计数据来实现强有力和一致的合作
所有 OSUCCC 研究项目和疾病特定研究小组 (DSRG) 的“导航员”,以及
为 OSUCCC 成员提供教育和生物统计培训; 3)提供生物统计和
对提交给 OSUCCC 临床科学审查委员会的所有癌症方案进行方法学审查
(CSRC) 和数据安全监测委员会 (DSMC),以及根据全面癌症护理 (TCC) 的需要
BSSR研究委员会。为了支持癌症研究中的团队科学,BSR 建立了一个导航器 -
系统于 2013 年推出,现已在本周期扩展到 OSU 和全国儿童医院的 20 个不同小组
医院 (NCH),生物统计学家隶属于每个 DSRG 并参与所有研究
从一开始就进行研究。导航员非常熟悉临床、生物学和统计问题
他们支持并充当在这些团体和更广泛的群体之间建立合作的关键人物
俄勒冈州立大学社区。所有五个 OSUCCC 项目均规定了办公时间,其中导航员
生物统计学家每隔一周在提供的空间呆上半天。 BSR还积极开展研讨会,
致力于培训生物医学研究人员设计、分析和分析基础知识的研讨会和课程
科学严谨。在当前周期中,BSR 使用 TCC 的基因组数据为个别研究人员提供支持
协议、俄勒冈州立大学肿瘤学研究信息交换网络 (ORIEN) Avatar 计划以及
国家以患者为中心的研究临床网络 (PaTH) 通过提供计算和编程
支持、数据可视化、图形和查询工具以及数据解释。 BSR 与其他合作伙伴一起工作
在协议的制定和实施过程中与 DSMC 和 CSRC 共享资源,以确保
通过强制应用可查找、可访问、符合 HIPAA 的流程和高数据质量,
可互操作和可重用 (FAIR) 准则。在本周期内,BSR 支持了 405 篇出版物
(59 > 10 影响因子)和 98 项 NIH (53 NCI) 资助,包括 26 R01、35 R21、1 R03、14 U01、5 U24、3
U19、3 架 U54、8 架 P01、2 架 P30、1 架 P50。在下一个拨款周期中,BSR 在新的战略优先事项中的作用
OSUCCC,包括免疫肿瘤学、转化基因组学、癌症工程和癌症预防
幸存者将大幅增加 BSR 的贡献,特别包括新招募的人员和
技术。 BSR 的年度预算为 4,063,515 美元,而 CCSG 的请求为 231,260 美元。因此,
BSR 利用广泛的机构支持,仅寻求 CCSG 基金 5.7% 的支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Soledad A Fernandez其他文献
Soledad A Fernandez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Soledad A Fernandez', 18)}}的其他基金
Opioid and SUD Data Enclave (O-SUDDEn): Bringing real-time data to the opioid crisis
阿片类药物和 SUD 数据飞地 (O-SUDDEn):为阿片类药物危机提供实时数据
- 批准号:
10590246 - 财政年份:2022
- 资助金额:
$ 32.86万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 32.86万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 32.86万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 32.86万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 32.86万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 32.86万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 32.86万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 32.86万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 32.86万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 32.86万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 32.86万 - 项目类别:














{{item.name}}会员




